Option Care Health, Inc. (OPCH)
| Market Cap | 3.58B -22.8% |
| Revenue (ttm) | 5.69B +5.9% |
| Net Income | 209.58M -0.8% |
| EPS | 1.32 +4.7% |
| Shares Out | 149.79M |
| PE Ratio | 18.08 |
| Forward PE | 14.91 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,195,557 |
| Open | 24.00 |
| Previous Close | 23.98 |
| Day's Range | 23.87 - 24.16 |
| 52-Week Range | 18.01 - 36.80 |
| Beta | 0.61 |
| Analysts | Buy |
| Price Target | 28.58 (+19.58%) |
| Earnings Date | Jul 29, 2026 |
About OPCH
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arth... [Read more]
Financial Performance
In 2025, Option Care Health's revenue was $5.65 billion, an increase of 13.03% compared to the previous year's $5.00 billion. Earnings were $207.59 million, a decrease of -2.00%.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for OPCH stock is "Buy." The 12-month stock price target is $28.58, which is an increase of 19.58% from the latest price.
News
Option Care Health Slides: Investor presentation
Option Care Health has posted slides in relation to its latest quarterly earnings report, which was published on August 3, 2026.
Option Care Health participates in a conference call with JPMorgan
JPMorgan holds a post 2Q earnings conference call with management on July 30 at 12 pm. Webcast Link
Option Care Health downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Option Care Health (OPCH) to Hold from Buy with a price target of $24, down from $26, following the Q2 report. There are concerns around CVS updating…
Option Care Health Earnings Call Transcript: Q2 2026
Q2 2026 results exceeded expectations with revenue of $1.4B, strong acute and rare/orphan growth, and robust cash flow. Guidance for 2026 remains unchanged, with continued investment in technology and commercial resources to drive sequential growth and margin improvement.
Option Care Health Earnings release: Q2 2026
Option Care Health released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Option Care Health Quarterly report: Q2 2026
Option Care Health has published its Q2 2026 quarterly earnings report on July 29, 2026.
Option Care Health reports Q2 adjusted EPS 45c, consensus 43c
Reports Q2 revenue $1.44B, consensus $1.42B. John C. Rademacher, Chief Executive Officer, commented, “I’m proud of our team as we delivered strong second quarter results, reflecting solid operational ...
Option Care Health narrows FY26 EPS view to $1.85-$1.92 from $1.82-$1.92
Consensus $1.84. Backs FY26 revenue view $5.68B-$5.78B, consensus $5.71B.
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
BANNOCKBURN, Ill., July 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate si...
Option Care Health downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Raj Kumar downgraded Option Care Health (OPCH) to Equal Weight from Overweight with a $24 price target
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
BANNOCKBURN, Ill., July 09, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion servic...
Option Care Health initiated with a Neutral at Goldman Sachs
Goldman Sachs initiated coverage of Option Care Health (OPCH) with a Neutral rating and $22 price target The firm says its rating balances the “durable” structural growth tailwinds in specialty…
Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced the appo...
Option Care Health management to meet with Citizens
Meeting to be held in the Midwest region on June 10 hosted by Citizens.
Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
BANNOCKBURN, Ill., June 01, 2026 (GLOBE NEWSWIRE) -- Option Care Health is proud to announce it has been ranked No. 15 on the World's Most Impactful Companies 2026 list, a global recognition of organi...
Option Care Health Slides: Investor presentation
Option Care Health has posted slides in relation to its latest quarterly earnings report, which was published on May 27, 2026.
Option Care Health Transcript: AGM 2026
The meeting saw all director nominees elected and key proposals, including auditor ratification and executive compensation, approved by strong majorities. 2025 financials showed solid growth despite industry challenges, with ongoing initiatives to improve patient care and address recent performance issues.
Option Care Health Transcript: Bank of America Global Healthcare Conference 2026
The session highlighted a disruptive Q1 with a $175M revenue guidance reduction, but EBITDA guidance was maintained through cost controls and operational focus. Investments in technology, commercial resources, and share repurchases are prioritized, while the business remains confident in long-term growth and portfolio diversification.
Option Care Health Slides: FY 2026
Option Care Health has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 12, 2026.
Option Care Health price target lowered to $28 from $38 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Option Care Health (OPCH) to $28 from $38 and keeps an Overweight rating on the shares.
Option Care Health to Participate in the Bank of America Health Care Conference
BANNOCKBURN, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion servic...
Option Care Health price target lowered to $33 from $40 at JPMorgan
JPMorgan lowered the firm’s price target on Option Care Health (OPCH) to $33 from $40 and keeps an Overweight rating on the shares.
Option Care Health price target lowered to $23 from $37 at TD Cowen
TD Cowen lowered the firm’s price target on Option Care Health (OPCH) to $23 from $37 and keeps a Hold rating on the shares. The firm said the second half…
Option Care Health price target lowered to $30 from $40 at Stephens
Stephens lowered the firm’s price target on Option Care Health (OPCH) to $30 from $40 and keeps an Overweight rating on the shares. Adverse chronic infusion dynamics will weigh on…
Option Care Health downgraded to Neutral from Buy at BofA
BofA analyst Joanna Gajuk downgraded Option Care Health (OPCH) to Neutral from Buy with a $22 price target The firm, which worries that pressures from payors and increased competition could…